The artificial intelligence expert uses a deep learning algorithm to develop an early detection and prevention system.<\/em><\/p>\n

New York City, NY, 19th\u00a0<\/strong>September 2023, ZEX PR WIRE<\/a>,<\/strong>\u00a0<\/strong>Machines permeate every sphere of the healthcare sector, save one: Prevention. When diseases are identified before they have the chance to display symptoms, their chances of progressing decrease exponentially. Visionary in the current climate, this goal is what Sai Nitisha Tadiboina sought to realize with Patent: 202241076373<\/u><\/a>.<\/p>\n

Even though screening techniques<\/u><\/a>\u00a0exist for screening people at high risk of diabetes and pancreatic cancer, there are no acute and objective methods for early detection. Deductive methods seldom work with diseases sharing multiple symptoms. A better technique is required to predict pancreatic cancer risk; this is where Tadiboina\u2019s Artificial Neural Network comes in.<\/p>\n

\u201cThe ANN is without a doubt better than any AI tool for detecting cancer risk that we have today,\u201d<\/em>\u00a0stated a source close to Tadiboina.\u00a0\u201cIt was created after studying the health records of hundreds of thousands of candidates on the Health Interview Survey and Pancreatic, Lung, Colorectal, and Ovarian Cancer databases. The data was used to design, train, and test the ANN. The algorithm is 87.3% sensitive and 80% specific during the screenings. It\u2019s anything but a baby step in the grand scheme of diseases with poor prognoses.\u201d<\/em><\/p>\n

Indeed, only one percent\u00a0of patients with advanced-stage pancreatic cancer can survive five years. On the other hand, diabetes\u00a0ranks among the top ten causes of death in the US. Tadiboina sees early detection as the only way of beating these illnesses. The artificial intelligence\u00a0researcher has worked tirelessly to propose lifesaving interventions in the healthcare field.<\/p>\n

Apart from diabetes and pancreatic cancer, Tadiboina has researched AI-based methods for detecting and treating breast cancer in women and men. Her treatment research focuses on developing personalized methods based on patient-related accounts. On the other hand, detection methods focus on early, less invasive, and more accurate methods of identifying carcinomas.<\/p>\n

Share insights with the AI expert. Connect with her on LinkedIn<\/u><\/a>.<\/p>\n

About Sai Nitisha Tadiboina<\/strong><\/p>\n

Sai Nitisha Tadiboina is a mentor, keynote speaker, and researcher in artificial intelligence, specifically machine learning. Her research focuses on the applications and uses of AI in healthcare and has recently expanded to cancer research. Connect with the AI expert for more insights and collaborations.<\/p>\n

Contact Details<\/strong><\/p>\n

Name:<\/strong>\u00a0Sai Nitisha Tadiboina<\/p>\n

Phone:<\/strong>\u00a0+1 631 480 4968<\/p>\n

Email:<\/strong>saitadiboina90@gmail.com<\/u><\/a><\/p>\n

LinkedIn: <\/strong>https:\/\/www.linkedin.com\/in\/sai-nitisha-tadiboina-2aa7b5162\/<\/u><\/a><\/p>\n<\/div>\n<\/div>\n

\nThe Post .NET Developer Sai Nitisha Tadiboina Makes Strides in AI-based Prevention of Diabetes and Pancreatic Cancer\t<\/a> first appeared on ZEX PR Wire<\/a> <\/p>\n<\/div>\n

Information contained on this page is provided by an independent third-party content provider. Binary News Network and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact contact@binarynewsnetwork.com<\/p>\n","protected":false},"excerpt":{"rendered":"

The artificial intelligence expert uses a deep learning algorithm to develop an early detection and prevention system. New York City, NY, 19th\u00a0September 2023, ZEX PR WIRE,\u00a0Machines permeate every sphere of the healthcare sector, save one: Prevention. When diseases are identified before they have the chance to display symptoms, their chances of progressing decrease exponentially. Visionary […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":{"0":"post-7020","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-news"},"_links":{"self":[{"href":"https:\/\/seoulchronicle.com\/wp-json\/wp\/v2\/posts\/7020"}],"collection":[{"href":"https:\/\/seoulchronicle.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/seoulchronicle.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/seoulchronicle.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/seoulchronicle.com\/wp-json\/wp\/v2\/comments?post=7020"}],"version-history":[{"count":0,"href":"https:\/\/seoulchronicle.com\/wp-json\/wp\/v2\/posts\/7020\/revisions"}],"wp:attachment":[{"href":"https:\/\/seoulchronicle.com\/wp-json\/wp\/v2\/media?parent=7020"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/seoulchronicle.com\/wp-json\/wp\/v2\/categories?post=7020"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/seoulchronicle.com\/wp-json\/wp\/v2\/tags?post=7020"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}